Orange Book product · Brand (NDA)
CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER
CEFOTAXIME SODIUM
At a glance
Jul 29, 2004
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 29, 2004
22 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFOTAXIME SODIUM
Strength
EQ 2GM BASE
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 050792
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1985CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINERBrand (NDA)
NDA 050596 · STERIMAX
- —CLAFORANBrand (NDA)
NDA 050547 · STERIMAX
- 2016CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 203132 · HOSPIRA
- 2010CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065348 · CEPHAZONE PHARMA
- 2009CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065517 · AUROBINDO PHARMA
- 2009CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065516 · AUROBINDO PHARMA LTD
- 2006CEFOTAXIMEGeneric (ANDA)
ANDA 065197 · WOCKHARDT
- 2006CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065290 · HOSPIRA INC
- 2006CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065293 · HOSPIRA INC
- 2006CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065292 · HOSPIRA INC
- 2003CEFOTAXIME SODIUMGeneric (ANDA)
ANDA 065124 · LUPIN
- 2002CEFOTAXIMEGeneric (ANDA)
ANDA 065072 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

